Class information for:
Level 1: PIOGLITAZONE//ROSIGLITAZONE//THIAZOLIDINEDIONES

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2787 2074 46.2 87%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
935 10411 PPAR GAMMA//PIOGLITAZONE//ROSIGLITAZONE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PIOGLITAZONE Author keyword 118 30% 16% 328
2 ROSIGLITAZONE Author keyword 91 26% 14% 300
3 THIAZOLIDINEDIONES Author keyword 80 29% 11% 229
4 THIAZOLIDINEDIONE Author keyword 29 22% 6% 116
5 TROGLITAZONE Author keyword 9 13% 3% 65
6 GLITAZONES Author keyword 9 27% 1% 29
7 GLITAZONE Author keyword 5 30% 1% 14
8 AVANDAMET Author keyword 4 75% 0% 3
9 VASC DIS PREVENT PROGRAM Address 4 56% 0% 5
10 CARDIOVASC METAB MED DEV Address 4 44% 0% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PIOGLITAZONE 118 30% 16% 328 Search PIOGLITAZONE Search PIOGLITAZONE
2 ROSIGLITAZONE 91 26% 14% 300 Search ROSIGLITAZONE Search ROSIGLITAZONE
3 THIAZOLIDINEDIONES 80 29% 11% 229 Search THIAZOLIDINEDIONES Search THIAZOLIDINEDIONES
4 THIAZOLIDINEDIONE 29 22% 6% 116 Search THIAZOLIDINEDIONE Search THIAZOLIDINEDIONE
5 TROGLITAZONE 9 13% 3% 65 Search TROGLITAZONE Search TROGLITAZONE
6 GLITAZONES 9 27% 1% 29 Search GLITAZONES Search GLITAZONES
7 GLITAZONE 5 30% 1% 14 Search GLITAZONE Search GLITAZONE
8 AVANDAMET 4 75% 0% 3 Search AVANDAMET Search AVANDAMET
9 RIVOGLITAZONE 3 100% 0% 3 Search RIVOGLITAZONE Search RIVOGLITAZONE
10 PPAR GAMMA AGONIST 3 17% 1% 14 Search PPAR+GAMMA+AGONIST Search PPAR+GAMMA+AGONIST

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ROSIGLITAZONE 70 19% 16% 339
2 TROGLITAZONE 65 23% 12% 245
3 PIOGLITAZONE 61 21% 12% 253
4 INDUCED FLUID RETENTION 52 80% 2% 32
5 THIAZOLIDINEDIONES 44 20% 9% 193
6 PIOGLITAZONE CLINICAL TRIAL 38 48% 3% 58
7 IMPROVES GLYCEMIC CONTROL 30 18% 7% 148
8 PIOGLITAZONE HYDROCHLORIDE 27 58% 1% 31
9 MACROVASCULAR EVENTS 22 47% 2% 35
10 LOWERS BLOOD PRESSURE 22 27% 3% 68

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Rosiglitazone Revisited An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality 2010 244 19 84%
Long-term risk of cardiovascular events with rosiglitazone - A meta-analysis 2007 432 15 73%
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies 2011 84 35 71%
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials 2007 560 25 56%
Thiazolidinediones and PPAR gamma agonists: time for a reassessment 2012 93 87 33%
Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes An Overview of Data from PROactive 2009 91 57 67%
Thiazolidinedione safety 2012 48 76 58%
Drug therapy: Thiazolidinediones 2004 1048 108 26%
Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis 2013 21 42 67%
Cardiovascular Outcomes in Trials of Oral Diabetes Medications - A Systematic Review 2008 139 58 47%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 VASC DIS PREVENT PROGRAM 4 56% 0.2% 5
2 CARDIOVASC METAB MED DEV 4 44% 0.3% 7
3 D CAMPANACCI CLIN MED PL BIOTECHNOL 3 22% 0.5% 10
4 G DESCOVICH ATHEROSCLEROSIS STUDY 2 17% 0.6% 12
5 COURSE ENDOCRINE SURG 2 67% 0.1% 2
6 ENDOCRINOL DIABETCARDIOVASC 2 67% 0.1% 2
7 LUDWIG BOLTZMANN PHYSIOL RHYTHMS 2 67% 0.1% 2
8 PEOPLES HOSP YANGZHOU 1 2 67% 0.1% 2
9 RENAL GRP MED 2 67% 0.1% 2
10 SECT ENDOCRINOL METAB HYPERTENS 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000246466 TROGLITAZONE//JTT 501//CAS 97322 87 7
2 0.0000159334 15D PGJ2//15 DEOXY DELTA12 14 PROSTAGLANDIN J2//PPAR RESEARCH
3 0.0000138229 PPAR DELTA//PPAR BETA DELTA//PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA
4 0.0000128151 ANTIDIABETIC PHARMACOTHERAPY//CHAIR GERIATR SURG//HEART FAILURE INCOR
5 0.0000108224 METFORMIN//LACTIC ACIDOSIS//METFORMIN ASSOCIATED LACTIC ACIDOSIS
6 0.0000105054 INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30
7 0.0000104073 PRO12ALA POLYMORPHISM//PRO12ALA//PPAR GAMMA 2
8 0.0000091197 GLICLAZIDE//INTERNAL MED DIABETOL CLIN PHARMACOL//DRUG QUAL CONTROL PHARMACOVIGILANC
9 0.0000084186 PPAR GAMMA//PPAR RESEARCH//TROGLITAZONE
10 0.0000077582 NATEGLINIDE//KAD 1229//REPAGLINIDE